一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Inhibitors>Afatinib (BIBW 2992)
Afatinib (BIBW 2992)
  • Afatinib (BIBW 2992)

Afatinib (BIBW 2992)

Price $1
Package 1g
Min. Order: 1g
Supply Ability: 1000kgs
Update Time: 2019-07-31

Product Details

Product Name: Afatinib (BIBW 2992) CAS No.: 439081-18-2
Min. Order: 1g Purity: 99%
Supply Ability: 1000kgs Release date: 2019/07/31

Small-Molecule Targeted Anti Tumor Inhibitor API  Afatinib 
(CAS: 439081-18-2)

Chemical Information
Quick Details:

Product Name Afatinib
Molecular Formula C24H25ClFN5O3
Molecular Weight 485.94
Storage 3years in -20ºC
Targets Abl c-Src
Dosage 30 nM; intraperitoneal injection
Target EGFR (L858R) EGFR (wt) EGFR (L858R/T790M) HER2
IC50 0.4 nM 0.5 nM 10 nM 14 nM

Product Name: Afatinib
Other Names:Afatinib;(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide;4-[(3-chloro-4-fluorophenyl)aMino]-6-{[4-(N,N-diMethylaMino)-1-oxo-2-buten-1-yl]aMino}-7-((S)-tetrahydrofuran-3-yloxy)-quinazoline;2-ButenaMide, N-[4-[(3-chloro-4-fluorophenyl)aMino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(diMethylaMino)-, (2E)-;(S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dime;Afatinib API;Afatinib(BIBW2992MA2);Afatinib (with 1 int.)
Model No.: ATC-136
CAS No.: 439081-18-2
Molecular Formula: C24H25ClFN5O3
Molecular Weight: 485.94
Appearance: White or Nearly White Crystalline Powder
Purity: 99%+
Product Specifications: Pharmaceutical Grade
        
Product Description
Afatinib (INN; trade name Gilotrif in the US and Giotrif in Europe, previously Tomtovok and Tovok) is a drug approved in United States, Europe, Taiwan, Mexico, Chile and Japan as well as other countries for the first-line treatment of patients with distinct types of metastatic (EGFR mutation positive) non-small cell lung carcinoma (NSCLC), developed by Boehringer Ingelheim. It acts as an irreversible covalent inhibitor of the receptor tyrosine kinases epidermal growth factor receptor (EGFR) and erbB-2 (HER2).

Applications/Usage
It has received regulatory approval for use as a treatment for non-small cell lung cancer, although there is emerging evidence to support its use in other cancers such as breast cancer.

COA Report:

Item

Requirements

Test Results

Description

Off-white powder

Off-white powder

Identification

HPLC ,NMR

Complies

Residue on Ignition

≤0.10%

0.05%

Loss on Drying

≤0.50%

0.15%

Heavy Metal

≤20ppm

<20ppm

Purity(HPLC)

≥99.0%

99.99%

Conclusion

It complies with EnterpriseStandard


FEATURED PRODUCT:

No. CAS No. Product Name
114977-28-5  
148408-66-6  
25316-40-9  
133040-01-4 Eprosartan
183321-74-6 Erlotinib
183319-69-9 Erlotinib Hydrochloride
159351-69-6 Everolimus
56296-78-7 Fluoxetine Hydrochloride
184475-55-6  
10  136572-09-3  
11  1441674-54-9 Ledipasvir(Acetone)
12  191732-72-6 Lenalidomide
13  21672   
14  76144-81-5 Mildronate
15  474645-27-7 Monomethyl Auristatin E
16  63121-00-6  
17  137281-23-3 Pemetrexed Disodium
18  53123-88-9 Rapamycin
19  945667-22-1 Saxagliptin Hydrate
20  709031-78-7 Saxagliptin Hydrochloride
 

Company Profile Introduction

You may like

Recommended supplier

Product name Price   Suppliers Update time
$29.00
VIP6Y
TargetMol Chemicals Inc.
2026-06-02
VIP2Y
Shaanxi Xianhe Biotech Co., Ltd
2026-06-02
VIP2Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2026-05-20
$5.00
Wuhan JiyunZen Tech Co., Ltd.
2026-04-10
VIP4Y
shandong perfect biotechnology co.ltd
2026-03-27
$10.00
Hebei Chuanghai Biotechnology Co., Ltd
2026-03-20
$1.10
VIP6Y
Dideu Industries Group Limited
2025-11-18
$5.00
VIP3Y
Henan Fengda Chemical Co., Ltd
2025-09-25
VIP4Y
Dingwang Technology (Wuhan) Co., Ltd.
2025-08-22
Hebei Yanxi Chemical Co., Ltd.
2025-06-20
  • Since: 2014-05-13
  • Address: Room 2004, Oriental Century Square Tower A, East Road Yellow River, Xinhua District, Cangzhou City
INQUIRY
晋中市| 赤城县| 泗水县| 桐梓县| 凤城市| 南城县| 陵水| 贵港市| 喀什市| 尤溪县| 姜堰市| 台北县| 育儿| 客服| 萨迦县| 砀山县| 武胜县| 南漳县| 青冈县| 宜兰县| 新田县| 滦南县| 吴堡县| 崇义县| 景谷| 视频| 金川县| 扎兰屯市| 兴仁县| 大安市| 大足县| 阿巴嘎旗| 皮山县| 龙海市| 苍溪县| 南通市| 达孜县| 无极县| 长汀县| 田阳县| 万山特区|